Researchers have altered the genetic code in a strain of Escherichia coli, reducing the number of stop codons from three to one and assigning the freed-up stop codons to nonstandard amino acids. They ...
As the flurry of executive orders continues to flow from the White House, leaving in its wake chaos and confusion across the ...
Once high-flying Bluebird Bio Inc. has found a way out of its financial squeeze, as funds managed by global investment firms ...
Researchers from Columbia University Irving Medical Center and collaborators applied unbiased scRNA-seq to study Lepr ...
In response to the news of reported layoffs at the U.S. FDA over the weekend, Advanced Medical Association president and CEO ...
Gene therapy specialist Meiragtx Holdings plc is heading for its first marketing approval following the successful treatment ...
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that ...
Using ALK+ lung cancer patient-derived cell lines, researchers have performed phosphoproteomic screening and identified ...
EG 427 SAS has closed a €27 million (US$28.3 million) series B round, which will fund it to completion of the first clinical ...
In a recently published study, researchers from Cima Universidad de Navarra and collaborators presented a novel SdAb-based ...
Perceive Pharma Inc., a spin out from Perceive Biotherapeutics Inc., has closed a $15 million series A funding round to help ...
Several Asia biotechs this week – including Innocare Pharma Ltd., Akeso Pharmaceuticals Inc., Sanbio Co. Ltd. and Ascletis Pharma Inc. – unveiled the start of new late-stage clinical trials or interim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback